Skip to main content
THC
NYSE Industrial Applications And Services

Tenet Healthcare Reports Strong Q2 Results, Raises Full-Year Outlook, and Boosts Buyback by $2.0 Billion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$199.05
Mkt Cap
$17.143B
52W Low
$146.6
52W High
$247.21
52W Position info
36% above low
Off High info
19% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

THC sits 36% above its 52-week low of $146.6.

Summary

Tenet Healthcare reported robust Q2 earnings, raised its full-year financial outlook, and authorized a substantial $2.0 billion increase to its share repurchase program.


Key Events · Earnings and Guidance · THC

  • Strong Q2 Financial Performance

    Net income available to common shareholders surged to $826 million ($9.84 diluted EPS) in Q2 2026, up from $288 million ($3.14 diluted EPS) in Q2 2025. Adjusted diluted EPS increased 52.2% to $6.12, and Consolidated Adjusted EBITDA grew 16.3% to $1.304 billion.

  • Raised Full-Year Guidance

    The company increased its FY 2026 Adjusted EBITDA outlook by $295 million at the midpoint to a new range of $4.83 billion to $5.03 billion. The FY 2026 Adjusted Free Cash Flow outlook was also raised by $225 million at the midpoint.

  • $2.0 Billion Share Buyback Increase

    The Board of Directors authorized a $2.0 billion increase to the existing share repurchase program, bringing the total remaining authorization to $2.13 billion. This follows $1.042 billion in repurchases during Q2 2026.


Analysis · THC · Industrial Applications And Services

The company delivered strong second-quarter financial results, significantly exceeding prior-year performance and analyst expectations. This strong operational execution led to a substantial increase in full-year financial guidance. Furthermore, the board authorized a significant $2.0 billion increase to its share repurchase program, demonstrating strong confidence in future performance and a commitment to returning capital to shareholders.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, THC was trading at $199.05 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $17.1B. The 52-week trading range was $146.60 to $247.21. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

THC - Latest Insights

THC
Oct 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $270.57
Real-time Price: $286.03 info
Change: +$15.46 (+6%) info
Market Cap: $22.765B info
THC
Oct 29, 2026, 1:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $263.65
Real-time Price: $286.03 info
Change: +$22.38 (+8%) info
Market Cap: $22.765B info
THC
Oct 29, 2026, 6:47 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $268.50
Real-time Price: $286.03 info
Change: +$17.53 (+7%) info
Market Cap: $22.765B info
THC
Oct 29, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $268.50
Real-time Price: $286.03 info
Change: +$17.53 (+7%) info
Market Cap: $22.765B info
THC
Sep 08, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $259.06
Real-time Price: $286.03 info
Change: +$26.97 (+10%) info
Market Cap: $22.765B info